Glycybridins A–K, Bioactive Phenolic Compounds from <i>Glycyrrhiza glabra</i>

In an attempt to discover bioactive agents from the herbal medicine <i>Glycyrrhiza glabra</i> (widely known as licorice), 11 new phenolic compounds, glycybridins A–K (<b>1</b>–<b>11</b>), along with 47 known phenolics (<b>12</b>–<b>58</b>) were isolated. Their structures were elucidated on the basis of extensive NMR and MS analyses as well as experimental and computed ECD data. According to the clinical therapeutic effects of licorice, enzyme or cell-based bioactivity screenings of <b>1</b>–<b>58</b> were conducted. A number of compounds significantly activate Nrf2, inhibit tyrosinase or PTP1B, inhibit LPS-induced NO production and NF-κB transcription, and inhibit the proliferation of human cancer cells (HepG2, SW480, A549, MCF7). Glycybridin D (<b>4</b>) showed moderate cytotoxic activities against the four cancer cell lines, with IC₅₀ values ranging from 4.6 to 6.6 μM. Further studies indicated that <b>4</b> (10 mg/kg, ip) decreased tumor mass by 39.7% on an A549 human lung carcinoma xenograft mice model, but showed little toxicity